Physician profile
Bobby Diniotis
NPI 1215348149
$8,911.86
in general payments reported to CMS, 2019-2025
39 companies · $2,754 in 2025
The $2,754 reported for 2025 was more than what 98% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $615 · 2020: $236 · 2021: $1,030 · 2022: $761 · 2023: $1,317 · 2024: $2,199 · 2025: $2,754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,918 · Travel and Lodging: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,918.42 |
| Travel and Lodging | $352.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,555.99 | 2021-2025 | Xact, Assurity, Gallant |
| Abiomed | $1,477.74 | 2023-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $822.25 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $763.91 | 2019-2025 | Farxiga, Brilinta |
| Novartis Pharmaceuticals Corporation | $618.27 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $492.03 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $274.97 | 2021-2025 | Jardiance |
| Shockwave Medical, INC | $259.36 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Amgen INC. | $237.67 | 2019-2025 | Repatha, Repatha |
| Esperion Therapeutics, INC. | $221.70 | 2021 | |
| Edwards Lifesciences Corporation | $220.62 | 2023-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Merck Sharp & Dohme LLC | $204.55 | 2021-2023 | Verquvo |
| Pfizer INC. | $173.03 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $167.88 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $161.18 | 2019-2025 | Camzyos, Eliquis |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $120.38 | 2019-2025 | Definity |
| Cardiovascular Systems INC. | $113.99 | 2020-2022 | |
| Veryan Medical Incorporated | $111.26 | 2021 | |
| Boston Scientific Corporation | $95.33 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $75.06 | 2024 | |
| Scpharmaceuticals INC. | $72.13 | 2024-2025 | |
| Penumbra, INC. | $70.55 | 2025 | Indigo System |
| Endologix LLC | $69.32 | 2025 | Alto Abdominal Stent Graft System |
| Acist Medical Systems, INC. | $58.73 | 2023-2024 | |
| Bracco Diagnostics INC. | $56.04 | 2022 | |
| Cleerly, INC. | $55.34 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Argon Medical Devices, INC. | $38.62 | 2025 | Clot Management |
| Vital Connect, INC | $38.57 | 2025 | Vitalpatch Rtm |
| Medtronic, INC. | $35.96 | 2021-2024 | Linq II |
| Idorsia Pharmaceuticals US INC | $33.22 | 2025 | Tryvio |
| Inari Medical, INC. | $29.30 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Mannkind Corporation | $29.06 | 2025 | |
| Biotronik INC. | $27.66 | 2025 | Acticor 7 Vr-T Dx |
| Stryker Corporation | $26.64 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Heartflow, INC. | $26.30 | 2024 | |
| Angiodynamics, INC. | $24.15 | 2024 | Alphavac |
| Teleflex LLC | $21.27 | 2023 | Supercross |
| Thrombolex, INC. | $18.25 | 2025 | Bashir Endovascular Catheter |
| Sunovion Pharmaceuticals INC. | $13.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bobby Diniotis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.